Guidant Expects Similar 20% Penetration Of Expanded ICD Market Via MADIT

Guidant projects the U.S. implantable defibrillator market will double to about $2.8 bil. as the applicable patient population expands based on indications evaluated in its recent MADIT II study. A related Guidant ICD PMA supplement was submitted in December 2001